Name: 7th Annual MarketsandMarkets Real-World Evidence and Life Sciences Analytics Conference
Start: 2024-10-17
End: 2024-10-18
Location: Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA

WHAT TO EXPECT

Gain insights into regulatory perspectives on data quality and standards, Integration of RWE into Clinical Trials
Explore the strategic utilization of Real-World Evidence (RWE) to enhance market access.
Regulatory Landscape for Medical Devices, Post-Market Surveillance and Safety Monitoring
Uncover the expanded realm of RWE's influence on digital health, Patient-Centric Approaches in Device Research
Examine the synergy between Real-World Data and Advanced Analytics, Economic impact evaluations using real-world evidence.
Epidemiological Insights using Real World Evidence

Latest insights and updates on trends
Networking opportunities
Professional Development
Interdisciplinary Learning
Insights into current regulatory perspectives
Access to Thought Leaders
Showcasing innovative technologies

From pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists within the following departments-

Real-World Evidence
Real-World Data
Data Analytics
Health Economics & Outcomes Research- HEOR
Market Access/Value Access
Policy
Clinical Development & research
Clinical trial
Centre for Observational and Real-World Evidence
Epidemiology
Oncology-RWE
Pricing and Reimbursement
Medical Affairs
Pharmacovigilance
Life Science Analytics
Big data
Data Science
Bio-Statistics
Consumer Healthcare

Others

Payers, Regulators, Research Institutes, and Innovation Centre

CONFERENCE AGENDA

Evidence Synergy: Bridging Outcomes, Access, and Analytics for Real-World Impact
Registration	08:15 - 08:50
Welcome note by MarketsandMarkets	08:50 - 08:55
Opening remarks by the Chairperson David Hall, Managing Director, AKT Health Inc.	08:55 - 09:00
Integration of RWE into Clinical Trials
Keynote Presentation: Demonstrating drug value: Outcomes are the currency, evidence is the backbone Charles Makin , Head of RWE, Boehringer-Ingelheim	09:00 - 09:30
Keynote Presentation - Optimizing Clinical Trials by Leveraging Real-World Data (Keynote) Jeff Trotter, Principal/Chief Evidence OfficerPrincipal / Chief Evidence Officer, J Trotter Research & Consulting	09:30 - 10:00
Navigating the maze of RWE frameworks from Regulatory and HTA agencies" , please see below some bullet points to expand on the topic for the agenda Anita Burrell, Senior Strategic Consultant in HEOR and Market Access, Anita Burrell Consulting LLC	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meeting	10:30 - 11:10
Patient-Centered Outcomes Research
Impact of Socio-Economic Factors on GLP1 Adoption and Outcomes Michael Sicilia, RWE Data Scientist, Forian	11:10 - 11:40
Owning the Value Narrative: Real-World Data’s Role in Trial Designs and Endpoint Selection Elizabeth Wu, Director, Health Economics and Real-World Evidence, Real Chemistry	11:40 - 12:10
Launch Smarter, Market Better: Leveraging Real-World Data in Challenging Therapeutic Areas Pete Pancione, VP, Life Sciences, Prognos Health	12:10 - 12:40
Incorporating Patient Perspectives into Research: New Approaches, New Diversity Measures Adrian Kielhorn, Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc	12:40 - 13:10
Lunch and Poster Presentation \| One-to-One Networking	13:10 - 14:10
Health Economics and Market Access
Real-World Data in Action: Regulatory Submissions and Risk Prediction Models Toni Donovan, AVP, Head of Commercial Team, Premier Inc. Zhun Cao, Senior Principal, Applied Research, Premier Inc.	14:10 - 14:40
Understanding the data leader’s role in establishing the value of RWD Lou Brooks, Senior Vice President, Real-World Data and Analytics, Optum Life Sciences Eric Fontana, Vice President, Client Solutions, Real-World Data, Optum Life Sciences	14:40 - 15:15
Using Patient-Generated Health Data for more Nuanced Clinical Outcomes for Medical Product Development Nancy Dreyer, Adjunct Professor of Epidemiology, University of North Carolina, Chapel Hill	15:15 - 15:55
Technological Innovations Driving Decentralized Clinical Trials and Real-World Evidence Aditya Tallapragada, President, AKT Health Inc	15:45 - 16:15
Evening Refreshments \| One-to-One Networking	16:15 - 16:15
AI and ML Applications in Life Sciences RWE
Accelerating clinical breakthroughs with clean EHR data, AI, and powerful analytics Conor Wyand, Senior Director, Life Science Solutions, Truveta	16:55 - 17:25
Machine learning-based models add predictive value to RWE studies by uncovering hidden risk factors and, by leveraging large amounts of diverse data, facilitate the design of personalized treatment strategies. This will be demonstrated through two case studies: Ramaa Nathan, VP, Data Science and RWE, EVERSANA	17:25 - 17:55
Closing remarks by the Chairperson David Hall, Managing Director, AKT Health Inc.	17:55 - 17:55

InnovateHealth: Precision Solutions in Evidence, Medicine, and Epidemiology
Registration	08:15 - 08:50
Welcome note by MarketsandMarkets	08:50 - 08:55
Opening remarks by the Chairperson Rashmi Gurnani, CEO, AKT Health Analytics	08:55 - 09:00
Healthcare Innovation and Technology
Leveraging AI and RWE for Enhanced Drug Safety Reese Sy, Director, Pfizer	09:00 - 09:30
Analytics Avengers: Assembling Winning RWE Teams Jyotsna Kasturi , Owner, HastaVantage Consulting	09:30 - 10:00
Beyond Clinical Trials: How Patient Reported Outcomes Impact Precision Medicine & Personalized Health Kevin Provost, CEO, Morebetter Ltd.	10:00 - 10:30
Morning Refreshments and Poster Presentation \| One-to-One Networking Meeting	10:30 - 11:10
Precision Medicine and Personalized Healthcare
Precision Medicine: The Way Forward! Prasun Mishra, Co-Founder, Precision BioPharma	11:10 - 11:40
Advancing Epidemiological Research: How AI, Expert Knowledge Integration, and Open-Source Platforms Will Shape Future Approaches Sonja Nakasian, Co-Founder, Bio Access Platforms	11:40 - 12:10
AI and ML in life sciences: Buzz words? or Reason for Optimism! Ravi Iyer, Sr. Director,Head Real World Evidence Global Health Economics, Value and Outcomes (Global HEVO), Teva Pharmaceuticals	12:10 - 12:40
The Role of Systematic Literature Reviews in Evidence Generation for clinical research Naisargi Patel, Data Scientist Regulatory and Real-World Evidence, Johnson & Johnson Innovative Medicine	12:40 - 13:10
Lunch and Poster Presentation \| One-to-One Networking	13:10 - 14:10
----End of Conference---	15:10 - 15:10